Dusa Pharmaceuticals Inc

Rediff.com » News » Dusa Pharmaceuticals Inc

News for Dusa Pharmaceuticals Inc

Business

Sun Pharma arm settles case with Biofrontera, to get $22.5 mn

Sun Pharmaceutical Industries on Tuesday said its arm DUSA Pharmaceuticals Inc has reached settlement with Biofrontera to resolve a litigation over misappropriation of trade secrets and unfair......

Sun Pharma keen to enter Japan's generics market

Sun Pharmaceutical Industries Ltd, India's biggest drugmaker by market value, is looking for partnerships or acquisitions to enter Japan, an especially lucrative market for manufacturers of......

Sun Pharma in talks to buy Meda for $5-$6 billion

Sun Pharmaceutical Industries Ltd is in talks to buy Swedish drugmaker MedaAB for $5 billion-$6 billion to boost its generics business in developed markets, two sources with direct knowledge of the......

Markets remain rangebound

Markets pared most of the day's gains as investors booked profits at higher levels ahead of the Christmas holiday tomorrow and expiry of December derivative contracts on Thursday.The 30-share......

Sun Pharma to acquire US-based DUSA for $230 million

Sun Pharmaceutical Industries on Thursday said it has inked a pact to acquire US-based DUSA Pharmaceuticals for around $230 million (around Rs 1,250 crore).Sun Pharma and DUSA Pharmaceuticals have......

Rediff News

Dusa Pharmaceuticals Inc

News for Dusa Pharmaceuticals Inc

Sun Pharma arm settles case with Biofrontera, to get $22.5 mn

Sun Pharma keen to enter Japan's generics market

Sun Pharma in talks to buy Meda for $5-$6 billion

Markets remain rangebound

Sun Pharma to acquire US-based DUSA for $230 million

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS